Liu Nan, Yang Yaxiong, Ge Lin, Liu Min, Colecraft Henry M, Liu Xiaodong
X-Lab for Transmembrane Signaling Research, Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China.
Department of Physiology and Cellular Biophysics, Columbia University, New York, United States.
Elife. 2017 Jan 6;6:e21989. doi: 10.7554/eLife.21989.
Inhibitions and antagonists of L-type Ca channels are important to both research and therapeutics. Here, we report C-terminus mediated inhibition (CMI) for Ca1.3 that multiple motifs coordinate to tune down Ca current and Ca influx toward the lower limits determined by end-stage CDI (Ca-dependent inactivation). Among IQ (preIQ-IQ domain), PCRD and DCRD (proximal or distal C-terminal regulatory domain), spatial closeness of any two modules, , by constitutive fusion, facilitates the trio to form the complex, compete against calmodulin, and alter the gating. Acute CMI by rapamycin-inducible heterodimerization helps reconcile the concurrent activation/inactivation attenuations to ensure Ca influx is reduced, in that Ca current activated by depolarization is potently (~65%) inhibited at the peak (full activation), but not later on (end-stage inactivation, ~300 ms). Meanwhile, CMI provides a new paradigm to develop Ca1 inhibitors, the therapeutic potential of which is implied by computational modeling of Ca1.3 dysregulations related to Parkinson's disease.
L型钙通道的抑制剂和拮抗剂对研究和治疗都很重要。在此,我们报告了Ca1.3的C末端介导抑制(CMI),多个基序协同作用,将钙电流和钙内流调节至由终末期CDI(钙依赖性失活)确定的下限。在IQ(前IQ - IQ结构域)、PCRD和DCRD(近端或远端C末端调节结构域)中,任何两个模块通过组成性融合在空间上靠近,有助于三者形成复合物,与钙调蛋白竞争并改变门控。雷帕霉素诱导的异二聚化引起的急性CMI有助于协调同时发生的激活/失活衰减,以确保钙内流减少,因为去极化激活的钙电流在峰值(完全激活)时被有效抑制(约65%),但在后期(终末期失活,约300毫秒)则不然。同时,CMI为开发Ca1抑制剂提供了一种新范式,与帕金森病相关的Ca1.3失调的计算模型暗示了其治疗潜力。